ANITA GILBERT: Open Payments
NPI 1124321088 · CHINO VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$622 in 29 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $622
Food & beverage: $622
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $143 |
| GlaxoSmithKline, LLC. | 6 | $113 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| Lilly USA, LLC | 2 | $36 |
| Verona Pharma, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $29 |
| Baxter Healthcare | 1 | $26 |
| Abbott Laboratories | 1 | $23 |
Products named: TRELEGY ELLIPTA, FARXIGA, AIRSUPRA, Veozah, Ohtuvayre, BREZTRI, CREON, Ozempic.
Industry payments across AZ — which companies pay providers there.
